William Segal, MD

Companies announce presentations at upcoming 2025 ARVO Annual Meeting

Gaining control of persistent corneal epithelial defects using AMT and a pressure patch

Alfredo A. Sadun, MD, PhD, discusses research targeting LHON

Minimizing the carbon footprint of ophthalmic surgeries

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco

Viatris' phase 3 trial of pimecrolimus 0.3% (MR-139) for blepharitis fails to meet primary end point